Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07601802 · ClinicalTrials.gov registry record
Acute Risk Monitoring for Oncology Therapy Regimen
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 4,740
- Enrollment target
NCT07601802 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 4,740 participants.
The verdict
NCT07601802 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 4,740 participants
- Enrollment target
Study Summary
Patients undergoing outpatient infusion systemic therapy for cancer are at risk for potentially preventable, unplanned acute care in the form of emergency department (ED) visits and hospitalizations. These events impact patient outcomes, treatment decisions, and healthcare costs. To address this need, the Centers for Medicare \& Medicaid Services developed the chemotherapy measure (OP-35). Recent randomized controlled studies indicate that electronic health record (EHR)-based machine learning (ML) approaches accurately direct supportive care to reduce acute care during radiotherapy. This study aims to develop and prospectively validate ML approaches to predict the risk of OP-35 qualifying, potentially preventable, acute care events within 30 days of infusion systemic therapy.
Interventions
- OTHER Medical record review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,740 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2024-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07601802
The ClinicalTrials.gov registry entry for NCT07601802 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,740 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medical record review is the first listed.
NCT07601802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07601802 about?
NCT07601802 is a clinical study titled "Acute Risk Monitoring for Oncology Therapy Regimen". Patients undergoing outpatient infusion systemic therapy for cancer are at risk for potentially preventable, unplanned acute care in the form of emergency department (ED) visits and hospitalizations. These events impact patient outcomes, treatment decisions, and healthcare costs. To address this nee...
What is the current status of trial NCT07601802?
This trial is currently completed. The enrollment target is 4,740 participants. The study started on 2017-07-01. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT07601802?
The interventions under investigation include: Medical record review (OTHER).
Who is sponsoring clinical trial NCT07601802?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.